Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea
· Delayed Price · Currency is KRW 5,640.00
-30.00 (-0.53%)
At close: Mar 25, 2025, 3:30 PM KST
Kyung Dong Pharmaceutical Revenue
Kyung Dong Pharmaceutical had revenue of 49.63B KRW in the quarter ending September 30, 2024, with 27.14% growth. This brings the company's revenue in the last twelve months to 189.19B, up 14.17% year-over-year. In the year 2023, Kyung Dong Pharmaceutical had annual revenue of 162.67B, down -10.97%.
Revenue (ttm)
189.19B
Revenue Growth
+14.17%
P/S Ratio
0.77
Revenue / Employee
532.79M
Employees
364
Market Cap
149.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 162.67B | -20.04B | -10.97% |
| Dec 31, 2022 | 182.72B | 5.11B | 2.88% |
| Dec 31, 2021 | 177.61B | 3.78B | 2.18% |
| Dec 31, 2020 | 173.83B | -2.67B | -1.51% |
| Dec 31, 2019 | 176.50B | -2.82B | -1.57% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |